pta20230817012
Half-yearly financial report according to article 125 BörseG

Marinomed Biotech AG: Half-yearly financial report according to article 125 BörseG

Korneuburg (pta012/17.08.2023/07:45 UTC+2) - Marinomed Biotech AG announces that the following financial reports shall be disclosed:


Report: Half year report 2023
Web publication: https://www.marinomed.com/en/investors-esg/financial-publications
Publication date: 17.08.2023

Short description: Half-yearly financial report 2023

(end)

Emitter: Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg
Austria
Contact Person: Pascal Schmidt, CFO
Phone: +43 2262 90300
E-Mail: pascal.schmidt@marinomed.com
Website: www.marinomed.com
ISIN(s): ATMARINOMED6 (Share)
Stock Exchange(s): Vienna Stock Exchange (Official Trade)
|